Alternatives to Moleculent

Clinical-stage biotech developing AI-driven metabolic immunotherapies for cancer and autoimmune diseases.

Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

AI-powered platform accelerating biological research and drug discovery.

Leveraging the adaptive immune system to diagnose and treat disease.

A global oncology company developing and commercializing innovative cancer treatments.

AI-powered platform for understanding disease biology and accelerating drug discovery.

AI-guided drug discovery platform for tissue-targeted medicines.

Phenomics-driven AI company translating disease biology into precision medicine discoveries.

AI-powered biotechnology company developing RNA therapeutics for genetic diseases.

Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.

Developing novel therapeutics targeting dysfunctional DNA packaging for diseases like cancer.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

Developing novel therapeutics by understanding the complex interplay of biological systems.

AI platform for drug discovery and development, accelerating research with advanced computational tools.

Biopharmaceutical company developing novel therapies for rare and ultra-rare genetic diseases.

Biotechnology company developing gene therapies and regenerative medicine for heart disease.

AI-powered platform for personalized cell therapy development and manufacturing.